pfizer glp 1 drug pulls out of GLP-1 race after safety concerns What the NY Times Got
Description
While studying GLP-1s and how effectively they treat diabetes, researchers discovered how significantly these medications can also affect a persons appetite, satiety, and food intake
Some early studies have even shown that people on these medicines lost less brain tissue and had a slower drop in their thinking skills
The advent of the first generic GLP-1 drugs could help Medicare negotiate a lower price for the highly sought after diabetes and obesity medication semaglutide, according to experts familiar with the price-negotiation program and STATs review of documents from the first round of negotiations
Diabetes Care (2022) 45(Suppl 1):S12543
The named individuals were not compensated for their help
